Novo Nordisk A/S – Share repurchase programme
30 Sep 2024 //
GLOBENEWSWIRE
Novo to decrease some insulin pen manufacturing, transition supply
28 Sep 2024 //
ENDPNTS
Novo Nordisk scolded yet again by UK drug marketing watchdog
26 Sep 2024 //
FIERCE PHARMA
Evotec and Novo Nordisk in technology development partnership
26 Sep 2024 //
REUTERS
Novo CEO agrees to discuss potential GLP-1 price cuts with PBMs
26 Sep 2024 //
FIERCE PHARMA
US Senator Sanders says middlemen won`t punish Novo
25 Sep 2024 //
REUTERS
Lawmakers urge government to allow generics to Novo GLP-1s
24 Sep 2024 //
FIERCE PHARMA
Novo CEO, Sanders to Face Off Over US Prices for Ozempic and Wegovy
24 Sep 2024 //
BIOSPACE
Novo Nordisk A/S - share repurchase programme
23 Sep 2024 //
GLOBENEWSWIRE
Novo: Ozempic Eligible For US Price Negotiations Soon
23 Sep 2024 //
REUTERS
Novo obesity prospect linked to Neuropsychiatric side effects
23 Sep 2024 //
FIERCEBIOTECH
Novo Nordisk Shares Drop On Disappointing Obesity Pill Data
21 Sep 2024 //
REUTERS
Novo Nordisk Faces US Grilling Over Weight Loss Drug Prices
21 Sep 2024 //
REUTERS
Novo Nordisk Completes Monlunabat Phase 2a Obesity Trial
20 Sep 2024 //
GLOBENEWSWIRE
EU regulator backs use of Novo`s Wegovy for obesity-related heart condition
20 Sep 2024 //
REUTERS
Novo Nordisk: Wegovy® Recommended For Label Update In EU
19 Sep 2024 //
GLOBENEWSWIRE
Novo bets $600M on NanoVation`s ability to take genetic medicines beyond liver
19 Sep 2024 //
FIERCE BIOTECH
NanoVation Partners With Novo Nordisk For Genetic Medicines
18 Sep 2024 //
BUSINESSWIRE
Novo Nordisk GBS launches safe pharmaceuticals disposal initiative for employees
18 Sep 2024 //
EXPRESSPHARMA
Hims & Hers offers compounded Wegovy for $99 a month to select professions
18 Sep 2024 //
REUTERS
Novo Nordisk`s latest RNA deal involves $530M biobucks to sing in Korro`s opera
17 Sep 2024 //
FIERCE BIOTECH
Novo Nordisk A/S - share repurchase programme
16 Sep 2024 //
GLOBENEWSWIRE
Novo Nordisk Reports Strong Weight Loss Results For Dual-Acting Oral Drug
11 Sep 2024 //
FIERCE BIOTECH
Novo`s older obesity drug is safe and effective for children, study finds
11 Sep 2024 //
REUTERS
Kallyope Announces License Agreement with Novo Nordisk
10 Sep 2024 //
BUSINESSWIRE
Novo Nordisk Obesity Pill Shows Mild-To-Moderate Side Effects In Early Trial
10 Sep 2024 //
REUTERS
Big Pharma Backs OAC`s `Your Weight Matters` Campaign Challenge
10 Sep 2024 //
FIERCE PHARMA
Terns` oral weight-loss drug shows promise in early study, shares jump
10 Sep 2024 //
REUTERS
Novo Nordisk A/S - share repurchase programme
09 Sep 2024 //
GLOBENEWSWIRE
Novo Nordisk To Present New Diabetes And Obesity Data At EASD Meeting
06 Sep 2024 //
PR NEWSWIRE
Lilly Gains Ground on Novo With Positive Phase III Readouts for Weekly Insulin
06 Sep 2024 //
BIOSPACE
Lilly`s Once-Weekly Insulin Shows Positive Data Vs Novo Nordisk
05 Sep 2024 //
FIERCE BIOTECH
Fake Ozempic: Batch Numbers Help Spread Dangerous Weight Loss Drugs
05 Sep 2024 //
REUTERS
Ozempic shortages in EU will not affect all member states - Novo Nordisk
03 Sep 2024 //
REUTERS
Novo Nordisk`s Ozempic shortage expected to continue into Q4
02 Sep 2024 //
REUTERS
Novo rekindles heart failure hopes for semaglutide with new pooled analysis
31 Aug 2024 //
FIERCE PHARMA
Novo Nordisk Reports Trading In Shares By Board And Executives
30 Aug 2024 //
GLOBENEWSWIRE
Catalent beats revenue estimates ahead of deal close with Novo Holdings
29 Aug 2024 //
REUTERS
Medicare Coverage of Novo’s Semaglutide for CVD Could Cost $145B Annually
28 Aug 2024 //
BIOSPACE
Novo Nordisk A/S - share repurchase programme
26 Aug 2024 //
GLOBENEWSWIRE
Novo Nordisk and Eli Lilly Likely to maintain clout in GLP-1R market
21 Aug 2024 //
ECONOMICTIMES
Novo Nordisk Reports Trading In Shares By Board Members And Executives
20 Aug 2024 //
GLOBENEWSWIRE
New Study Adds To Ongoing Debate On Suicidal Ideation Risk For Ozempic
20 Aug 2024 //
FIERCE PHARMA
Novo Nordisk A/S - share repurchase programme
19 Aug 2024 //
GLOBENEWSWIRE
Novo Nordisk plans new $220M raw ingredients plant in Denmark
16 Aug 2024 //
FIERCE PHARMA
Doctors struggle to get Wegovy for older Americans with heart disease
15 Aug 2024 //
REUTERS
Novo Nordisk: Trading Of Shares By Board Members, Executives, And Associates
14 Aug 2024 //
GLOBENEWSWIRE
Novo Nordisk Plans 2024 FDA Filing For Weekly Insulin-Semaglutide Combo
13 Aug 2024 //
FIERCE PHARMA
Novo Nordisk Foundation to establish India’s first ‘Sickle Cell Wellness Hub’
12 Aug 2024 //
EXPRESSPHARMA
Novo Nordisk Reports Insider Trading By Board And Executives
12 Aug 2024 //
GLOBENEWSWIRE
Novo Nordisk A/S – Share repurchase programme
12 Aug 2024 //
GLOBENEWSWIRE
Novo Nordisk`s H1 sales increased by 24% in Danish kroner
12 Aug 2024 //
INDIANPHARMAPOST
5 Obesity Readouts to Watch in the Second Half of 2024
09 Aug 2024 //
BIOSPACE
Novo Nordisk Breaches UK Marketing Rules With CEO`s Wegovy Interview
09 Aug 2024 //
FIERCE PHARMA
Novo Nordisk Reports Insider Trading
09 Aug 2024 //
GLOBENEWSWIRE
Novo Nordisk: Trading In Shares By Board Members And Executives
08 Aug 2024 //
GLOBENEWSWIRE
Novo Nordisk Reports 25% Sales Growth At Constant Exchange Rates In H1 2024
07 Aug 2024 //
GLOBENEWSWIRE
Novo Nordisk axes once-monthly GLP-1/GIP agonist and MASH prospect
07 Aug 2024 //
FIERCE BIOTECH
Novo Nordisk Pulls Wegovy`s FDA Heart Failure Submission
07 Aug 2024 //
FIERCE PHARMA
Novo Nordisk`s Wegovy Doubles US Prescriptions From Start Of Year
07 Aug 2024 //
FIERCE PHARMA